Carlsmed (CARL) Stock Forecast & Price Target

CARL Forecast - Frequently Asked Questions

What is Carlsmed's forecast for 2026?

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Carlsmed is $19.67, with a high forecast of $24.00 and a low forecast of $17.00.

Should I buy or sell Carlsmed stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Carlsmed in the last year. There is currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CARL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CARL, but not buy additional shares or sell existing shares.

Does Carlsmed's stock price have much upside?

According to analysts, Carlsmed's stock has a predicted upside of 120.48% based on their 12-month stock forecasts.

Has Carlsmed been upgraded or downgraded by Wall Street analysts recently?

Over the previous 90 days, Carlsmed's stock had 1 upgrade and 1 downgrade by analysts.

What analysts cover Carlsmed?

Carlsmed has been rated by research analysts at The Goldman Sachs Group, Truist Financial, and Zacks Research in the past 90 days.

Do Wall Street analysts like Carlsmed more than its competitors?

Analysts like Carlsmed more than other "manufacturing" companies. The consensus rating score for Carlsmed is 2.40 while the average consensus rating score for "manufacturing" companies is 2.05. Learn more on how CARL compares to other companies.